Q Chip develops advanced life science and therapeutic products using its proprietary MicroPlant platform for the production of precision loaded polymer microspheres. The company was founded in October 2003, and has secured approximately £400,000 revenues and approximately £3.2 million of equity investment from groups including CPF, E-Synergy, Finance Wales and Biofusion. These investments have enabled Q Chip to develop and now exploit three core precision microsphere products:
- ReaX – for advanced bead based molecular reagents and cell assays
- BiologiX – benign and efficient encapsulation system for the delivery and sustained release of biopharmaceutical drugs
- IonX – microsphere system for delivery and controlled release of small molecule therapies.